Souhaitez-vous accéder aux communiqués récents ?

Company earns Gold Seal of Approval® for Ambulatory Health Care Accreditation PETACH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an...

Nanox to Participate in Three Upcoming Investor Conferences in May 2024

Nanox Files 2023 Annual Report on Form 20-F

AhealthZ to aid Nanox’s pursuit of local authorizations and licenses for Nanox.ARC in South Korea SCL Science to integrate Nanox’s artificial intelligence solutions in operations PETAH TIKVA,...

Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update

Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024

– According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average –...

First patients in clinical study at Beilinson Hospital were scanned with the Nanox.ARC, a stationary X-ray system that produces 3D tomographic images Study may help determine clinical utility of...

Nanox’s HealthFLD is pioneering the use of a fully automated AI software for liver attenuation analysis from CT scans that has received FDA 510(k) clearance for use in general population Expands...

Nanox Mourns Death of Its Founder, Ran Poliakine